Duchenne肌营养不良-话题@MedSci

#Duchenne肌营养不良#

9篇内容 | 300人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1784819, encodeId=be6e1e848198c, content=<a href='/topic/show?id=303063212d' target=_blank style='color:#2F92EE;'>#Duchenne肌营养不良#</a>, objectTitle=Neurology：未经糖皮质激素治疗的Duchenne肌营养不良症男孩患者的临床和遗传学特征, objectType=article, longId=221574, objectId=510d2215e451, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=510d2215e451, replyNumber=0, likeNumber=32, createdTime=2022-03-29, rootId=0, userName=fmq_28614553, userId=0a3a2500014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=510d2215e451, moduleTitle=Neurology：未经糖皮质激素治疗的Duchenne肌营养不良症男孩患者的临床和遗传学特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=510d2215e451)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1784820, encodeId=a33e1e84820cd, content=<a href='/topic/show?id=303063212d' target=_blank style='color:#2F92EE;'>#Duchenne肌营养不良#</a>, objectTitle=Lancet：晚期Duchenne肌营养不良症(HOPE-2)重复静脉注射心肌衍生细胞治疗：一项多中心、随机、双盲、安慰剂对照的2期试验, objectType=article, longId=301136, objectId=bb463011360c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb463011360c, replyNumber=0, likeNumber=30, createdTime=2022-11-05, rootId=0, userName=fmq_28614553, userId=0a3a2500014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb463011360c, moduleTitle=Lancet：晚期Duchenne肌营养不良症(HOPE-2)重复静脉注射心肌衍生细胞治疗：一项多中心、随机、双盲、安慰剂对照的2期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb463011360c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1784818, encodeId=4a931e84818c7, content=<a href='/topic/show?id=303063212d' target=_blank style='color:#2F92EE;'>#Duchenne肌营养不良#</a>, objectTitle=外显子跳跃疗法Vyondys 53治疗Duchenne肌营养不良症, objectType=article, longId=184766, objectId=e208184e66d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e208184e66d1, replyNumber=0, likeNumber=36, createdTime=2020-07-16, rootId=0, userName=fmq_28614553, userId=0a3a2500014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e208184e66d1, moduleTitle=外显子跳跃疗法Vyondys 53治疗Duchenne肌营养不良症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e208184e66d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1784817, encodeId=739d1e848173d, content=<a href='/topic/show?id=303063212d' target=_blank style='color:#2F92EE;'>#Duchenne肌营养不良#</a>, objectTitle=英国MHRA为Vamorolone授予创新药物称号（PIM），用于治疗Duchenne肌营养不良, objectType=article, longId=181707, objectId=6c06181e0759, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c06181e0759, replyNumber=0, likeNumber=36, createdTime=2020-01-20, rootId=0, userName=fmq_28614553, userId=0a3a2500014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c06181e0759, moduleTitle=英国MHRA为Vamorolone授予创新药物称号（PIM），用于治疗Duchenne肌营养不良, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c06181e0759)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1784815, encodeId=9cfb1e8481520, content=<a href='/topic/show?id=303063212d' target=_blank style='color:#2F92EE;'>#Duchenne肌营养不良#</a>, objectTitle=Duchenne肌营养不良症：辉瑞基因疗法的早期数据, objectType=article, longId=174496, objectId=0b581e449609, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b581e449609, replyNumber=0, likeNumber=35, createdTime=2019-10-26, rootId=0, userName=fmq_28614553, userId=0a3a2500014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b581e449609, moduleTitle=Duchenne肌营养不良症：辉瑞基因疗法的早期数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b581e449609)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1784814, encodeId=64a01e848148d, content=<a href='/topic/show?id=303063212d' target=_blank style='color:#2F92EE;'>#Duchenne肌营养不良#</a>, objectTitle=FibroGen 的CTGF单抗pamrevlumab治疗Duchenne肌营养不良症，获得FDA孤儿药指定, objectType=article, longId=164435, objectId=61d1164435c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61d1164435c5, replyNumber=0, likeNumber=34, createdTime=2019-11-27, rootId=0, userName=fmq_28614553, userId=0a3a2500014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61d1164435c5, moduleTitle=FibroGen 的CTGF单抗pamrevlumab治疗Duchenne肌营养不良症，获得FDA孤儿药指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61d1164435c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1784816, encodeId=d22a1e848164a, content=<a href='/topic/show?id=303063212d' target=_blank style='color:#2F92EE;'>#Duchenne肌营养不良#</a>, objectTitle=辉瑞的Duchenne肌营养不良症基因疗法1b期展现出药效，但是安全问题引发了竞争对手股价上涨, objectType=article, longId=174689, objectId=57431e468941, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57431e468941, replyNumber=0, likeNumber=37, createdTime=2020-03-04, rootId=0, userName=fmq_28614553, userId=0a3a2500014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57431e468941, moduleTitle=辉瑞的Duchenne肌营养不良症基因疗法1b期展现出药效，但是安全问题引发了竞争对手股价上涨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57431e468941)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1784812, encodeId=2b1a1e8481297, content=<a href='/topic/show?id=303063212d' target=_blank style='color:#2F92EE;'>#Duchenne肌营养不良#</a>, objectTitle=PNAS：如何无创监测Duchenne肌营养不良症疾病进展, objectType=article, longId=144180, objectId=80ad144180f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80ad144180f0, replyNumber=0, likeNumber=41, createdTime=2018-09-05, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80ad144180f0, moduleTitle=PNAS：如何无创监测Duchenne肌营养不良症疾病进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80ad144180f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1784813, encodeId=d6981e8481333, content=<a href='/topic/show?id=303063212d' target=_blank style='color:#2F92EE;'>#Duchenne肌营养不良#</a>, objectTitle=Capricor的新型细胞疗法显着改善了Duchenne肌营养不良症患者的骨骼和心肌功能, objectType=article, longId=159122, objectId=6519159122ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6519159122ab, replyNumber=0, likeNumber=41, createdTime=2019-06-26, rootId=0, userName=fmq_28614553, userId=0a3a2500014, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6519159122ab, moduleTitle=Capricor的新型细胞疗法显着改善了Duchenne肌营养不良症患者的骨骼和心肌功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6519159122ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Duchenne肌营养不良

2020-05-29

fmq_28614553 (审核中...)

前往app查看评论内容

#Duchenne肌营养不良#

Neurology：未经糖皮质激素治疗的Duchenne肌营养不良症男孩患者的临床和遗传学特征

2022-03-29

fmq_28614553 (审核中...)

前往app查看评论内容

#Duchenne肌营养不良#

Lancet：晚期Duchenne肌营养不良症(HOPE-2)重复静脉注射心肌衍生细胞治疗：一项多中心、随机、双盲、安慰剂对照的2期试验

2022-11-05

fmq_28614553 (审核中...)

前往app查看评论内容

#Duchenne肌营养不良#

外显子跳跃疗法Vyondys 53治疗Duchenne肌营养不良症

2020-07-16

fmq_28614553 (审核中...)

前往app查看评论内容

#Duchenne肌营养不良#

英国MHRA为Vamorolone授予创新药物称号（PIM），用于治疗Duchenne肌营养不良

2020-01-20

fmq_28614553 (审核中...)

前往app查看评论内容

#Duchenne肌营养不良#

Duchenne肌营养不良症：辉瑞基因疗法的早期数据

2019-10-26

fmq_28614553 (审核中...)

前往app查看评论内容

#Duchenne肌营养不良#

FibroGen 的CTGF单抗pamrevlumab治疗Duchenne肌营养不良症，获得FDA孤儿药指定

2019-11-27

fmq_28614553 (审核中...)

前往app查看评论内容

#Duchenne肌营养不良#

辉瑞的Duchenne肌营养不良症基因疗法1b期展现出药效，但是安全问题引发了竞争对手股价上涨

2020-03-04

仁心济世 (审核中...)

前往app查看评论内容

#Duchenne肌营养不良#

PNAS：如何无创监测Duchenne肌营养不良症疾病进展

2018-09-05

fmq_28614553 (审核中...)

前往app查看评论内容

#Duchenne肌营养不良#

Capricor的新型细胞疗法显着改善了Duchenne肌营养不良症患者的骨骼和心肌功能

2019-06-26

科室
- - 订阅+
  - 更多科室
工具
服务